Organogenesis Holdings Inc. financial data

Symbol
ORGO on Nasdaq
Location
85 Dan Road, Canton, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 373 % +31.6%
Quick Ratio 42.9 % +27.5%
Debt-to-equity 43.8 % -32.1%
Return On Equity 0.4 %
Return On Assets 0.21 %
Operating Margin -1.8 % +36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127M shares -4.27%
Common Stock, Shares, Outstanding 127M shares -4.27%
Entity Public Float 200M USD -15.2%
Common Stock, Value, Issued 13K USD 0%
Weighted Average Number of Shares Outstanding, Basic 127M shares -4.3%
Weighted Average Number of Shares Outstanding, Diluted 131M shares -2.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 465M USD +2.24%
Cost of Revenue 111M USD +2.03%
Research and Development Expense 45.8M USD -9.35%
Operating Income (Loss) -8.38M USD +34.4%
Nonoperating Income (Expense) 2.17M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.2M USD +58.2%
Income Tax Expense (Benefit) -7.21M USD +3.57%
Net Income (Loss) Attributable to Parent 1.01M USD +74.9%
Earnings Per Share, Basic 0 USD/shares -83.3%
Earnings Per Share, Diluted 0 USD/shares -83.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 63.7M USD -32.4%
Accounts Receivable, after Allowance for Credit Loss, Current 169M USD +66.7%
Inventory, Net 39.6M USD +46.4%
Assets, Current 300M USD +25.7%
Deferred Income Tax Assets, Net 45.6M USD +27%
Property, Plant and Equipment, Net 78.1M USD -13.1%
Operating Lease, Right-of-Use Asset 33.3M USD -4.69%
Intangible Assets, Net (Excluding Goodwill) 9.94M USD -25.3%
Goodwill 28.8M USD 0%
Other Assets, Noncurrent 14.4M USD +187%
Assets 510M USD +14.2%
Accounts Payable, Current 40.2M USD +67.8%
Employee-related Liabilities, Current 31.4M USD +37.5%
Accrued Liabilities, Current 40.3M USD +11.7%
Liabilities, Current 90.3M USD +16.9%
Operating Lease, Liability, Noncurrent 23.5M USD +3.17%
Other Liabilities, Noncurrent 2.51M USD +93.9%
Liabilities 124M USD -26.2%
Retained Earnings (Accumulated Deficit) -46.8M USD +2.1%
Stockholders' Equity Attributable to Parent 255M USD -8.41%
Liabilities and Equity 510M USD +14.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.9M USD -96.2%
Net Cash Provided by (Used in) Financing Activities -2.06M USD +21.2%
Net Cash Provided by (Used in) Investing Activities -3.63M USD -63.2%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 128M shares -4.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.6M USD -70.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 64.4M USD -32.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.38M USD +8.18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 50M USD +20.9%
Operating Lease, Liability 138M USD +176%
Depreciation 14.8M USD +14.1%
Payments to Acquire Property, Plant, and Equipment 3.63M USD +63.2%
Lessee, Operating Lease, Liability, to be Paid 147M USD +152%
Property, Plant and Equipment, Gross 135M USD -6.79%
Operating Lease, Liability, Current 4.79M USD +21.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -1.27M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.33M USD +4.57%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 870K shares -13%
Unrecognized Tax Benefits 873K USD -46.1%
Operating Lease, Payments 2.72M USD +10%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 3.36M USD -11.6%
Depreciation, Depletion and Amortization 14M USD +12.1%
Deferred Tax Assets, Net of Valuation Allowance 39.5M USD +40.9%
Interest Expense 2.08M USD +16.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%